Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-15

Clinical Trial Update: Efficacy and Safety of Opicapone in Clinical Practice [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy and safety of opicapone in Parkinson's disease with wearing-off motor fluctuations in real-world clinical practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OpiCapone

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease With Wearing-off Motor Fluctuations | Phase 4 | Status: COMPLETED